S1200 Characterization of Hospitalized Patients With Ulcerative Colitis Treated With Tofacitinib in the OCTAVE Clinical Program for up to 7.8 Years

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAmerican Journal of Gastroenterology
DOIs
Publication statusPublished - 2023

Keywords

  • Tofacitinib
  • Medicine
  • Octave (electronics)
  • Ulcerative colitis
  • Placebo
  • Janus kinase inhibitor
  • Internal medicine
  • Gastroenterology
  • Disease
  • Rheumatoid arthritis
  • Physics
  • Alternative medicine
  • Pathology
  • Optics

Cite this